Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
about
Miz1 deficiency in the mammary gland causes a lactation defect by attenuated Stat5 expression and phosphorylationGynaecomastia--pathophysiology, diagnosis and treatmentA comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.Minireview: Tipping the balance: ligand-independent activation of steroid receptors.Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processesNongenomic signaling pathways of estrogen toxicity.Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.Estrogens of multiple classes and their role in mental health disease mechanisms.What can we learn from rodents about prolactin in humans?The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells.Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression.Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic miceProlactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fosComplex prolactin crosstalk in breast cancer: new therapeutic implicationsThe combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study.Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation.Proteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cellsJAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?Therapeutic potential of S179D prolactin--from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulator.Review of the epidemiological literature on antidepressant use and breast cancer risk.Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.Plasma prolactin and breast cancer risk: a meta- analysis.Regulation of prolactin receptor levels and activity in breast cancerA 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancerProlactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivoTriennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.Activation of the unliganded estrogen receptor by prolactin in breast cancer cells.Reversed Expression of the JAK/STAT Pathway Related Proteins Prolactin Receptor and STAT5a in Normal and Abnormal Breast Epithelial Cells.Toremifene use does not alter serum inhibin A and B levels during mid-luteal phase in women with premenstrual mastalgia.Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas.The prolactin receptor: Diverse and emerging roles in pathophysiology.The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer.A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations.
P2860
Q27321385-BEB97F2E-22F9-4981-BF66-FB51F4FF6C03Q28245725-3941004D-54B2-451D-A7D1-11B53674F8AFQ33308309-3CD7AD1C-D37B-4DEC-8C3C-734D2912C19CQ33631775-53D28957-D847-4307-B06A-17796DA4AA4AQ33740398-B653A79A-E13B-467C-BC09-F9A11D0B0DB6Q33988964-B4B40F62-892A-46A3-B330-15F9BD0AA49EQ34225990-E6FEB2E0-3FC3-4607-A0C9-2688E6D60E9EQ34272184-AFF21F4C-DEDF-403A-8C04-2D5D57261E96Q34721567-A47361A5-DFE0-42BB-BDB8-1BDA0FADDADEQ34856382-A9A82228-CBD2-4006-B957-7E8B99B4A627Q34994336-1B03088F-443E-45FD-81CE-064F85D3ECBBQ35088089-56499367-5878-410C-9731-00498FD9C8C9Q35088209-FD12F90D-4A3D-4AEA-B6AC-7877B3FB99C3Q35121907-3FE9746E-2A1D-4191-9EFD-44D06ABA459CQ35303180-14299B3E-B780-4FA8-A517-FFF0427A8B84Q35683588-F6A3FADA-041D-4505-B8B6-91E784869C54Q35828199-87EF553D-F21A-4FE7-9555-21E0E174BFC2Q35990940-659CDD25-2F72-434F-BB49-298B5C5DEC3FQ36178175-508B2C35-6C30-44C7-9359-CF4CF62A1244Q36600303-62633F09-6197-492B-889F-C6A98B16A29EQ36607352-B53F264B-C33B-428C-8FCE-4B05142CC983Q36629985-1EB8C4B9-080D-4F72-81FC-4DC8B0296CD5Q36906706-A8CEAF13-D8F5-4281-86A7-D2E7C395D625Q37060370-789C9BD5-4D4B-4A99-9CF5-32ED05363A42Q37082963-AD744ABE-F39D-4CB7-A5DF-07D7ACC5650FQ37150832-AEFF3CB7-21F3-4C55-9DB6-47363A0F7B60Q37302064-05738A2D-AAE9-4D4B-B732-9AA1984E1508Q37331101-3225F1BC-6ABF-49B0-8DF4-26B8AD4FFFCDQ37972125-1108E16D-FF1A-4C2E-9B58-99B0C07973D0Q39262264-97564E93-96F3-405D-8ADF-BA599D24A3B1Q39890928-7B911630-2977-4969-B785-69DA7DEE2CF9Q42730817-D9095384-DBB4-4F9D-900A-ED964C54D991Q43194604-E2D8CC26-BA08-4790-8B4A-3F1FA0DD2672Q44130924-CD39D60A-1BC8-4CE1-B03C-4D21D444DC78Q47137743-A128A767-20B6-4C4C-A02B-966548D78D56Q55033417-80508D5C-F725-42A7-8900-231810EFAC99Q55669305-75F4B139-DB4F-4F46-95E1-DF103E8CE9A1
P2860
Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Endogenous human prolactin and ...... veness in breast cancer cells.
@en
type
label
Endogenous human prolactin and ...... veness in breast cancer cells.
@en
prefLabel
Endogenous human prolactin and ...... veness in breast cancer cells.
@en
P2093
P1476
Endogenous human prolactin and ...... veness in breast cancer cells.
@en
P2093
Jennifer H Gutzman
Kristin K Miller
Linda A Schuler
P356
10.1016/J.JSBMB.2003.10.008
P577
2004-01-01T00:00:00Z